CDK5 and stroke disorder: CIP is a derived-p35 cleavage peptide, which selectively targets Cdk5/p25 activity without affecting Cdk5/p35 signalling [16], suggesting that CIP may represent a novel selective vascular protector/stimulator in hypoxic conditions such as those encountered after stroke.